Outdoor Exposure to Chemical TCE May Raise Risk of Parkinson’s
A large nationwide study finds that long-term exposure to a common industrial chemical in outdoor air is associated with an increased risk of Parkinson’s disease among older adults.
Category: Parkinson’s Disease
Parkinson’s Disease
Latest
Parkinson’s Disease
Latest
Robot Therapy to Treat Tremor
Researchers have developed SPINDLE robotic rehabilitation to enhance the strength and dexterity of individuals with tremors.
Parkinson’s Disease
Latest
Michael J. Fox Foundation Awards $2.5M to Develop DTx App for Parkinson’s
The grant will be used to advance the research and development of Soturi, a digital therapeutic solution for Parkinson's treatment.
Parkinson’s Foundation and Tag.bio Partner to Accelerate Parkinson’s Research
The Parkinson’s Foundation and Tag.bio announce a partnership that will help accelerate research into the causes and treatment of PD.
Read More
Artificial Intelligence Helps Diagnose Parkinson’s
Researchers used artificial intelligence techniques to estimate parameters such as step length, width, and velocity to diagnose Parkinson’s.
Read More
Parkinson’s Foundation Launches New Online Education Series
Education Series for Community Providers is a six-part online education series offering PD information for medically underserved communities.
Read More
Parkinson’s Monitor App Parky Gets FDA Nod
The FDA-cleared Parky App monitors Parkinson’s symptoms such as tremors and dyskinesia in real time via the use of the Apple Watch.
Read More
NIH-Funded Parkinson’s Trial to Use Integrated Motion Analysis Suite
A second generation Integrated Motion Analysis Suite is being used as part of an NIH-funded trial investigating ESStim for Parkinson’s.
Read More
This Helps Improve Constipation in Parkinson’s Patients
ENT-01 is safe for up to 25 days of treatment and helps improve constipation and possibly neurological symptoms in Parkinson’s patients.
Read More
Esya Labs Receives $452K MJFF Grant to Develop Peripheral Markers for Parkinson’s Disease
Esya Labs will be partnering with MSD to validate peripheral biomarkers for Parkinson’s disease and accelerate therapeutics development.
Read More
Research Collaboration Forms to Study Parkinson’s Dementia
Enterin Inc and Parkinson’s Virtual Biotech, part of Parkinson’s UK, are collaborating to study ENT-01 effects on Parkinson’s dementia.
Read More
First World Movement Disorders Day: November 29
The International Parkinson and Movement Disorder Society (MDS) is launching the first World Movement Disorders Day on November 29, 2022.
Read More
Weight Changes in Early Parkinson’s May Be Tied to Changes in Thinking Skills
People with weight changes after Parkinson’s diagnosis may be more likely to have thinking skills changes than people who maintain weight.
Read More
CMS Sets Price for Cala TAPS Therapy for Essential Tremor
CMS’s decision expands access for Medicare patients with essential tremor who could benefit from Cala TAPS therapy.
Read More
In-Home Wireless Device Tracks Disease Progression in Parkinson’s Patients
By continuously monitoring a patient’s gait speed, the system can assess Parkinson’s severity between visits to the doctor’s office.
Read More
Discovery Illuminates How Parkinson’s Disease Spreads in the Brain
Aggregates of the protein alpha-synuclein spread in the brains of people with Parkinson’s disease through a cellular waste-ejection process.
Read More
Researchers Uncover Where and Why Proteins Malfunction in Parkinson’s Disease
Researchers discover how a build-up of protein starts to happen within neurons in Parkinson’s disease, ultimately causing nerve cell death.
Read More
New Survey Results Reveal the Significant Impact of OFF Time on People with Parkinson’s Disease and Their Care Partners
PMD Alliance and Neurocrine Biosciences announce results of a survey revealing the impact of OFF Time on people with Parkinson’s disease.
Read More